Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma

Reactivity of a monoclonal antibody with human ovarian carcinoma.

Robert C. Bast, Maryellen Feeney, Herbert Lazarus et al. · Journal of Clinical Investigation · 1981 · 1.7K citations · Full text

Medicine, Cancer Biology, Oncology +17

A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer

Ian Jacobs, D Oram, J. Fairbanks et al. · BJOG An International Journal of Obstetrics & Gynaecology · 1990 · 963 citations

Medicine, Gynecology, Oncology +17

Uterine papillary serous carcinoma

Michael Hendrickson, Jon Ross, Patricia J. Eifel et al. · The American Journal of Surgical Pathology · 1982 · 676 citations

Veterinary Medicine, Oncology, Pathology +12

Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125.

G.J.S. Rustin, Ann E. Nelstrop, Patrick McClean et al. · Journal of Clinical Oncology · 1996 · 380 citations

Medicine, Gynecology, Oncology +15

Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.

Ian Jacobs, A. Davies, Jackie Bridges et al. · BMJ · 1993 · 366 citations · Full text

Medicine, Gynecology, Oncology +16